Entero <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Subsidiary ImmunogenX, LLC Settles Legal Dispute with $7.9 Million Settlement Agreement
Entero Therapeutics Inc.'s wholly-owned subsidiary, ImmunogenX, LLC, has recently entered into a notable settlement agreement with Mattress Liquidators Inc., Jack A. Syage, and The Jack A. Syage and Elizabeth T. Syage Revocable Trust. As part of the agreement, the Guarantors have committed to pay $5,500,000 towards settling obligations amounting to approximately $7.9 million owed to the Plaintiff. This payment was completed on April 9, 2025. The agreement also involves the release of Mattress Liquidators Inc.'s security interest in ImmunogenX, LLC. Additionally, both parties have agreed to execute a Stipulation of Dismissal with Prejudice, which will be filed with the District Court in Boulder County, Colorado. This development marks a significant step for ImmunogenX, LLC in resolving its financial obligations.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-048544), on May 14, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。